University Library
  • Login
A gateway to Melbourne's research publications
Minerva Access is the University's Institutional Repository. It aims to collect, preserve, and showcase the intellectual output of staff and students of the University of Melbourne for a global audience.
View Item 
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Florey Department of Neuroscience and Mental Health
  • Florey Department of Neuroscience and Mental Health - Research Publications
  • View Item
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Florey Department of Neuroscience and Mental Health
  • Florey Department of Neuroscience and Mental Health - Research Publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

    High-throughput screening campaign identifies a small molecule agonist of the relaxin family peptide receptor 4

    Thumbnail
    Citations
    Altmetric
    Author
    Lin, G-Y; Lin, L; Cai, X-Q; Dai, A-T; Zhu, Y; Li, J; Liu, Q; Yang, D-H; Bathgate, RAD; Wang, M-W
    Date
    2020-03-31
    Source Title
    Acta Pharmacologica Sinica
    Publisher
    NATURE PUBLISHING GROUP
    University of Melbourne Author/s
    Bathgate, Ross
    Affiliation
    Florey Department of Neuroscience and Mental Health
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Lin, G. -Y., Lin, L., Cai, X. -Q., Dai, A. -T., Zhu, Y., Li, J., Liu, Q., Yang, D. -H., Bathgate, R. A. D. & Wang, M. -W. (2020). High-throughput screening campaign identifies a small molecule agonist of the relaxin family peptide receptor 4. ACTA PHARMACOLOGICA SINICA, 41 (10), pp.1328-1336. https://doi.org/10.1038/s41401-020-0390-x.
    Access Status
    Access this item via the Open Access location
    URI
    http://hdl.handle.net/11343/254427
    DOI
    10.1038/s41401-020-0390-x
    Open Access URL
    https://europepmc.org/articles/PMC7608467?pdf=render
    Abstract
    Relaxin/insulin-like family peptide receptor 4 (RXFP4) is a class A G protein-coupled receptor (GPCR), and insulin-like peptide 5 (INSL5) is its endogenous ligand. Although the precise physiological role of INSL5/RXFP4 remains elusive, a number of studies have suggested it to be a potential therapeutic target for obesity and other metabolic disorders. Since selective agonists of RXFP4 are scarcely available and peptidic analogs of INSL5 are hard to make, we conducted a high-throughput screening campaign against 52,000 synthetic and natural compounds targeting RXFP4. Of the 109 initial hits discovered, only 3 compounds were confirmed in secondary screening, with JK0621-D008 displaying the best agonism at human RXFP4. Its S-configuration stereoisomer (JK1) was subsequently isolated and validated by a series of bioassays, demonstrating a consistent agonistic effect in cells overexpressing RXFP4. This scaffold may provide a valuable tool to further explore the biological functions of RXFP4.

    Export Reference in RIS Format     

    Endnote

    • Click on "Export Reference in RIS Format" and choose "open with... Endnote".

    Refworks

    • Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References


    Collections
    • Minerva Elements Records [53102]
    • Florey Department of Neuroscience and Mental Health - Research Publications [1300]
    Minerva AccessDepositing Your Work (for University of Melbourne Staff and Students)NewsFAQs

    BrowseCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    My AccountLoginRegister
    StatisticsMost Popular ItemsStatistics by CountryMost Popular Authors